CN Stock MarketDetailed Quotes

002252 Shanghai RAAS Blood Products

Watchlist
  • 7.88
  • -0.08-1.01%
Market Closed Jul 2 15:00 CST
52.37BMarket Cap28.76P/E (TTM)

Shanghai RAAS Blood Products Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-0.33%2.06B
21.27%7.96B
19.87%5.94B
18.43%3.9B
22.40%2.06B
53.16%6.57B
62.53%4.95B
87.59%3.29B
97.32%1.69B
55.26%4.29B
Operating revenue
-0.33%2.06B
21.27%7.96B
19.87%5.94B
18.43%3.9B
22.40%2.06B
53.16%6.57B
62.53%4.95B
87.59%3.29B
97.32%1.69B
55.26%4.29B
Other operating revenue
----
19.10%1.57M
----
15.78%874.58K
----
-56.07%1.32M
----
39.20%755.37K
----
202.31%3.01M
Total operating cost
6.02%1.44B
22.98%5.55B
22.14%4.09B
21.03%2.69B
24.52%1.36B
62.93%4.51B
76.47%3.35B
111.76%2.22B
118.40%1.09B
63.28%2.77B
Operating cost
6.94%1.24B
28.57%4.72B
26.88%3.45B
22.87%2.24B
26.81%1.16B
77.56%3.67B
93.00%2.72B
142.65%1.82B
156.84%915.43M
96.69%2.07B
Operating tax surcharges
42.43%12.36M
14.89%37.69M
32.25%28.33M
35.13%19.84M
21.46%8.68M
42.32%32.81M
35.51%21.42M
42.97%14.68M
38.10%7.15M
13.21%23.05M
Operating expense
-21.12%66.68M
-10.53%333.76M
0.18%284.44M
10.04%194.65M
-2.99%84.54M
21.85%373.03M
25.82%283.94M
36.19%176.88M
34.10%87.15M
51.96%306.13M
Administration expense
-1.01%95.59M
13.66%378.98M
6.34%250.81M
3.72%163.62M
40.10%96.57M
7.38%333.45M
12.90%235.86M
13.75%157.74M
2.86%68.93M
-5.19%310.52M
Financial expense
33.38%-24.61M
-121.98%-91.58M
-511.51%-48.77M
-5.29%-14.07M
-75.34%-36.95M
36.97%-41.26M
78.02%-7.98M
44.77%-13.36M
-42.80%-21.07M
-95.34%-65.46M
-Interest expense (Financial expense)
-33.61%21.59K
-54.50%119.75K
-62.02%84.54K
-67.94%60.73K
-75.39%32.51K
-44.25%263.18K
-35.14%222.62K
2.85%189.4K
188.36%132.1K
25.50%472.09K
-Interest Income (Financial expense)
-4.98%-32.95M
-37.71%-135.38M
-53.55%-101.79M
-70.28%-67.64M
-71.34%-31.38M
-77.38%-98.31M
-120.08%-66.29M
-51.85%-39.72M
-36.47%-18.31M
-25.63%-55.42M
Research and development
8.84%50.09M
19.24%173.74M
29.74%132.45M
35.24%86.87M
33.77%46.02M
12.93%145.71M
31.32%102.09M
46.03%64.23M
62.59%34.4M
-0.52%129.02M
Credit Impairment Loss
-125.07%-2.66M
131.87%5.22M
105.70%1.2M
141.20%6.72M
186.17%10.6M
-251.24%-16.38M
-592.92%-21.01M
-407.36%-16.32M
-370.17%-12.3M
374.20%10.83M
Asset Impairment Loss
157.10%1.22M
88.45%-24M
-51.11%-9.31M
-275.35%-2.48M
-59.24%-2.13M
44.01%-207.72M
-18.28%-6.16M
193.94%1.41M
-345.75%-1.34M
-166.82%-370.97M
Other net revenue
116.78%301.21M
-185.55%-190.72M
-8.88%274.8M
27.73%249.48M
166.32%138.94M
527.27%222.92M
-31.76%301.58M
-39.26%195.31M
-57.62%52.17M
-91.84%35.54M
Fair value change income
--0
-319.57%-40.36M
-227.78%-23.58M
916.67%39.16M
122.13%10.79M
142.99%18.38M
80.22%-7.19M
87.50%-4.8M
-7.96%-48.75M
-143.18%-42.76M
Invest income
129.31%268.7M
-137.30%-153.82M
-7.74%298.58M
-2.56%201.3M
6.05%117.18M
0.42%412.39M
-29.00%323.64M
-38.33%206.58M
-30.15%110.49M
-26.04%410.67M
-Including: Investment income associates
-23.38%89.78M
-138.27%-157.82M
-8.98%294.58M
-4.49%197.3M
6.05%117.18M
1.41%412.39M
-28.37%323.64M
-37.59%206.58M
-30.15%110.49M
-25.38%406.67M
Asset deal income
-1,450.67%-1.15M
-105.50%-12.49K
-99.67%252.18
-99.97%12.02
150.79%85.08K
116.80%227.19K
108.33%76.79K
104.15%34.9K
105.11%33.92K
-239.07%-1.35M
Other revenue
1,345.89%35.1M
38.91%22.26M
-35.29%7.91M
-43.18%4.77M
-39.82%2.43M
-44.99%16.02M
-49.76%12.22M
-61.81%8.4M
-28.72%4.03M
-27.42%29.12M
Operating profit
8.75%915.96M
-2.35%2.23B
11.30%2.12B
15.30%1.46B
30.44%842.27M
46.60%2.28B
19.64%1.9B
23.16%1.26B
35.27%645.69M
3.51%1.55B
Add:Non operating Income
91.24%105.48K
712.15%2.42M
47.21%542.41K
-39.98%153.43K
7.51%55.16K
-28.82%297.57K
2.01%368.46K
-10.78%255.65K
-2.38%51.3K
-72.83%418.08K
Less:Non operating expense
940.15%12.96M
316.59%23.66M
324.35%8.86M
152.95%3.53M
134.39%1.25M
-64.41%5.68M
-86.25%2.09M
-52.12%1.39M
-67.71%531.55K
-38.89%15.96M
Total profit
7.37%903.11M
-3.06%2.2B
10.96%2.11B
15.14%1.46B
30.36%841.08M
47.73%2.27B
20.65%1.9B
23.36%1.26B
35.62%645.21M
4.18%1.54B
Less:Income tax cost
18.90%146.03M
6.50%426.65M
7.38%321.68M
5.48%217.25M
23.77%122.82M
60.19%400.61M
65.31%299.58M
77.47%205.97M
94.23%99.23M
57.64%250.09M
Net profit
5.40%757.08M
-5.10%1.78B
11.63%1.79B
17.02%1.24B
31.55%718.27M
45.31%1.87B
14.84%1.6B
16.45%1.06B
28.57%545.99M
-2.25%1.29B
Net profit from continuing operation
5.40%757.08M
-5.10%1.78B
11.63%1.79B
17.02%1.24B
31.55%718.27M
45.31%1.87B
14.84%1.6B
16.45%1.06B
28.57%545.99M
-2.25%1.29B
Less:Minority Profit
186.54%261.39K
71.18%-2.04M
53.35%-1.99M
64.30%-1.16M
85.24%-302.04K
-27.50%-7.09M
-26.04%-4.26M
-59.95%-3.24M
-46.90%-2.05M
-8.63%-5.56M
Net profit of parent company owners
5.32%756.82M
-5.35%1.78B
11.46%1.79B
16.77%1.24B
31.12%718.57M
45.24%1.88B
14.87%1.6B
16.55%1.06B
28.63%548.03M
-2.21%1.29B
Earning per share
Basic earning per share
6.54%0.114
-3.57%0.27
11.76%0.266
17.20%0.184
32.10%0.107
47.37%0.28
14.98%0.238
16.30%0.157
28.57%0.081
-9.52%0.19
Diluted earning per share
6.54%0.114
-3.57%0.27
11.76%0.266
17.20%0.184
32.10%0.107
47.37%0.28
14.98%0.238
16.30%0.157
28.57%0.081
-9.52%0.19
Other composite income
125.21%47.95M
-77.83%271.39M
-68.88%456.98M
-17.11%568.04M
-184.80%-190.19M
450.35%1.22B
1,718.65%1.47B
626.42%685.31M
-181.26%-66.78M
60.18%-349.36M
Other composite income of parent company owners
125.21%47.95M
-77.83%271.39M
-68.88%456.98M
-17.11%568.04M
-184.80%-190.19M
450.35%1.22B
1,718.65%1.47B
626.42%685.31M
-181.26%-66.78M
60.18%-349.36M
Total composite income
52.45%805.02M
-33.84%2.05B
-26.91%2.24B
3.60%1.81B
10.20%528.07M
229.61%3.1B
135.64%3.07B
123.99%1.74B
-5.45%479.21M
112.92%939.59M
Total composite income of parent company owners
52.31%804.76M
-33.93%2.05B
-26.95%2.24B
3.47%1.81B
9.79%528.37M
228.42%3.1B
135.36%3.07B
123.82%1.75B
-5.31%481.25M
111.72%945.15M
Total composite income of minority owners
186.54%261.39K
71.18%-2.04M
53.35%-1.99M
64.30%-1.16M
85.24%-302.04K
-27.50%-7.09M
-26.04%-4.26M
-59.95%-3.24M
-46.90%-2.05M
-8.63%-5.56M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -0.33%2.06B21.27%7.96B19.87%5.94B18.43%3.9B22.40%2.06B53.16%6.57B62.53%4.95B87.59%3.29B97.32%1.69B55.26%4.29B
Operating revenue -0.33%2.06B21.27%7.96B19.87%5.94B18.43%3.9B22.40%2.06B53.16%6.57B62.53%4.95B87.59%3.29B97.32%1.69B55.26%4.29B
Other operating revenue ----19.10%1.57M----15.78%874.58K-----56.07%1.32M----39.20%755.37K----202.31%3.01M
Total operating cost 6.02%1.44B22.98%5.55B22.14%4.09B21.03%2.69B24.52%1.36B62.93%4.51B76.47%3.35B111.76%2.22B118.40%1.09B63.28%2.77B
Operating cost 6.94%1.24B28.57%4.72B26.88%3.45B22.87%2.24B26.81%1.16B77.56%3.67B93.00%2.72B142.65%1.82B156.84%915.43M96.69%2.07B
Operating tax surcharges 42.43%12.36M14.89%37.69M32.25%28.33M35.13%19.84M21.46%8.68M42.32%32.81M35.51%21.42M42.97%14.68M38.10%7.15M13.21%23.05M
Operating expense -21.12%66.68M-10.53%333.76M0.18%284.44M10.04%194.65M-2.99%84.54M21.85%373.03M25.82%283.94M36.19%176.88M34.10%87.15M51.96%306.13M
Administration expense -1.01%95.59M13.66%378.98M6.34%250.81M3.72%163.62M40.10%96.57M7.38%333.45M12.90%235.86M13.75%157.74M2.86%68.93M-5.19%310.52M
Financial expense 33.38%-24.61M-121.98%-91.58M-511.51%-48.77M-5.29%-14.07M-75.34%-36.95M36.97%-41.26M78.02%-7.98M44.77%-13.36M-42.80%-21.07M-95.34%-65.46M
-Interest expense (Financial expense) -33.61%21.59K-54.50%119.75K-62.02%84.54K-67.94%60.73K-75.39%32.51K-44.25%263.18K-35.14%222.62K2.85%189.4K188.36%132.1K25.50%472.09K
-Interest Income (Financial expense) -4.98%-32.95M-37.71%-135.38M-53.55%-101.79M-70.28%-67.64M-71.34%-31.38M-77.38%-98.31M-120.08%-66.29M-51.85%-39.72M-36.47%-18.31M-25.63%-55.42M
Research and development 8.84%50.09M19.24%173.74M29.74%132.45M35.24%86.87M33.77%46.02M12.93%145.71M31.32%102.09M46.03%64.23M62.59%34.4M-0.52%129.02M
Credit Impairment Loss -125.07%-2.66M131.87%5.22M105.70%1.2M141.20%6.72M186.17%10.6M-251.24%-16.38M-592.92%-21.01M-407.36%-16.32M-370.17%-12.3M374.20%10.83M
Asset Impairment Loss 157.10%1.22M88.45%-24M-51.11%-9.31M-275.35%-2.48M-59.24%-2.13M44.01%-207.72M-18.28%-6.16M193.94%1.41M-345.75%-1.34M-166.82%-370.97M
Other net revenue 116.78%301.21M-185.55%-190.72M-8.88%274.8M27.73%249.48M166.32%138.94M527.27%222.92M-31.76%301.58M-39.26%195.31M-57.62%52.17M-91.84%35.54M
Fair value change income --0-319.57%-40.36M-227.78%-23.58M916.67%39.16M122.13%10.79M142.99%18.38M80.22%-7.19M87.50%-4.8M-7.96%-48.75M-143.18%-42.76M
Invest income 129.31%268.7M-137.30%-153.82M-7.74%298.58M-2.56%201.3M6.05%117.18M0.42%412.39M-29.00%323.64M-38.33%206.58M-30.15%110.49M-26.04%410.67M
-Including: Investment income associates -23.38%89.78M-138.27%-157.82M-8.98%294.58M-4.49%197.3M6.05%117.18M1.41%412.39M-28.37%323.64M-37.59%206.58M-30.15%110.49M-25.38%406.67M
Asset deal income -1,450.67%-1.15M-105.50%-12.49K-99.67%252.18-99.97%12.02150.79%85.08K116.80%227.19K108.33%76.79K104.15%34.9K105.11%33.92K-239.07%-1.35M
Other revenue 1,345.89%35.1M38.91%22.26M-35.29%7.91M-43.18%4.77M-39.82%2.43M-44.99%16.02M-49.76%12.22M-61.81%8.4M-28.72%4.03M-27.42%29.12M
Operating profit 8.75%915.96M-2.35%2.23B11.30%2.12B15.30%1.46B30.44%842.27M46.60%2.28B19.64%1.9B23.16%1.26B35.27%645.69M3.51%1.55B
Add:Non operating Income 91.24%105.48K712.15%2.42M47.21%542.41K-39.98%153.43K7.51%55.16K-28.82%297.57K2.01%368.46K-10.78%255.65K-2.38%51.3K-72.83%418.08K
Less:Non operating expense 940.15%12.96M316.59%23.66M324.35%8.86M152.95%3.53M134.39%1.25M-64.41%5.68M-86.25%2.09M-52.12%1.39M-67.71%531.55K-38.89%15.96M
Total profit 7.37%903.11M-3.06%2.2B10.96%2.11B15.14%1.46B30.36%841.08M47.73%2.27B20.65%1.9B23.36%1.26B35.62%645.21M4.18%1.54B
Less:Income tax cost 18.90%146.03M6.50%426.65M7.38%321.68M5.48%217.25M23.77%122.82M60.19%400.61M65.31%299.58M77.47%205.97M94.23%99.23M57.64%250.09M
Net profit 5.40%757.08M-5.10%1.78B11.63%1.79B17.02%1.24B31.55%718.27M45.31%1.87B14.84%1.6B16.45%1.06B28.57%545.99M-2.25%1.29B
Net profit from continuing operation 5.40%757.08M-5.10%1.78B11.63%1.79B17.02%1.24B31.55%718.27M45.31%1.87B14.84%1.6B16.45%1.06B28.57%545.99M-2.25%1.29B
Less:Minority Profit 186.54%261.39K71.18%-2.04M53.35%-1.99M64.30%-1.16M85.24%-302.04K-27.50%-7.09M-26.04%-4.26M-59.95%-3.24M-46.90%-2.05M-8.63%-5.56M
Net profit of parent company owners 5.32%756.82M-5.35%1.78B11.46%1.79B16.77%1.24B31.12%718.57M45.24%1.88B14.87%1.6B16.55%1.06B28.63%548.03M-2.21%1.29B
Earning per share
Basic earning per share 6.54%0.114-3.57%0.2711.76%0.26617.20%0.18432.10%0.10747.37%0.2814.98%0.23816.30%0.15728.57%0.081-9.52%0.19
Diluted earning per share 6.54%0.114-3.57%0.2711.76%0.26617.20%0.18432.10%0.10747.37%0.2814.98%0.23816.30%0.15728.57%0.081-9.52%0.19
Other composite income 125.21%47.95M-77.83%271.39M-68.88%456.98M-17.11%568.04M-184.80%-190.19M450.35%1.22B1,718.65%1.47B626.42%685.31M-181.26%-66.78M60.18%-349.36M
Other composite income of parent company owners 125.21%47.95M-77.83%271.39M-68.88%456.98M-17.11%568.04M-184.80%-190.19M450.35%1.22B1,718.65%1.47B626.42%685.31M-181.26%-66.78M60.18%-349.36M
Total composite income 52.45%805.02M-33.84%2.05B-26.91%2.24B3.60%1.81B10.20%528.07M229.61%3.1B135.64%3.07B123.99%1.74B-5.45%479.21M112.92%939.59M
Total composite income of parent company owners 52.31%804.76M-33.93%2.05B-26.95%2.24B3.47%1.81B9.79%528.37M228.42%3.1B135.36%3.07B123.82%1.75B-5.31%481.25M111.72%945.15M
Total composite income of minority owners 186.54%261.39K71.18%-2.04M53.35%-1.99M64.30%-1.16M85.24%-302.04K-27.50%-7.09M-26.04%-4.26M-59.95%-3.24M-46.90%-2.05M-8.63%-5.56M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --KPMG Huazhen Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg